Nephro-Urology Monthly

Published by: Kowsar

Assessment of Prevalence of Chronic Kidney Disease and Its Predisposing Factors in Kerman City

Azadeh Saber 1 , Ahmad Naghibzadeh Tahami 2 , Hamid Najafipour 3 and Jalal Azmandian 4 , *
Authors Information
1 Assistant Professor of Nephrology, Physiology Research Center, Institute of Neuropharmacoloy, Kerman University of Medical Sciences, Kerman, IR Iran
2 MSc in Epidemiology, Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, IR Iran
3 Professor of Physiology, Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, IR Iran
4 Associate Professor of Nephrology, Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, IR Iran
Article information
  • Nephro-Urology Monthly: March 2017, 9 (2); e13113
  • Published Online: January 25, 2017
  • Article Type: Research Article
  • Received: August 26, 2016
  • Revised: October 22, 2016
  • Accepted: January 21, 2017
  • DOI: 10.5812/numonthly.41794

To Cite: Saber A, Naghibzadeh Tahami A, Najafipour H, Azmandian J. Assessment of Prevalence of Chronic Kidney Disease and Its Predisposing Factors in Kerman City, Nephro-Urol Mon. 2017 ; 9(2):e13113. doi: 10.5812/numonthly.41794.

Copyright © 2017, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Methods
3. Results
4. Discussion
  • 1. Lederer E, Ouseph R. Chronic kidney disease. Am J Kidney Dis. 2007; 49(1): 162-71[DOI][PubMed]
  • 2. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6): 2089-100[DOI][PubMed]
  • 3. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008; 8: 117[DOI][PubMed]
  • 4. Chin HJ, Ahn JM, Na KY, Chae DW, Lee TW, Heo NJ, et al. The effect of the World Kidney Day campaign on the awareness of chronic kidney disease and the status of risk factors for cardiovascular disease and renal progression. Nephrol Dial Transplant. 2010; 25(2): 413-9[DOI][PubMed]
  • 5. Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ. The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med. 2009; 169(12): 1104-12[DOI][PubMed]
  • 6. Leal VO, Delgado AG, Leite M Jr, Mitch WE, Mafra D. Influence of renal function and diet on acid-base status in chronic kidney disease patients. J Ren Nutr. 2009; 19(2): 178-82[DOI][PubMed]
  • 7. Kovesdy CP, Kalantar-Zadeh K. Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol. 2008; 40(2): 427-40[DOI][PubMed]
  • 8. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009; 24(8): 2446-52[DOI][PubMed]
  • 9. Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2014; (4)[DOI][PubMed]
  • 10. Kiberd B. The chronic kidney disease epidemic: stepping back and looking forward. J Am Soc Nephrol. 2006; 17(11): 2967-73[DOI][PubMed]
  • 11. Rao M, Pereira BJ. Chronic kidney disease in India-a hidden epidemic. Indian J Med Res. 2007; 126(1): 6
  • 12. Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl. 2005; (98)-7[DOI][PubMed]
  • 13. Clase CM, Kiberd BA, Garg AX. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III). Nephron Clin Pract. 2007; 105(4)-84[DOI][PubMed]
  • 14. Selvin E, Manzi J, Stevens LA, Van Lente F, Lacher DA, Levey AS, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007; 50(6): 918-26[DOI][PubMed]
  • 15. Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE, et al. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl. 2004; (92)-21[DOI][PubMed]
  • 16. Viktorsdottir O, Palsson R, Andresdottir MB, Aspelund T, Gudnason V, Indridason OS. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant. 2005; 20(9): 1799-807[DOI][PubMed]
  • 17. Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study. Arch Intern Med. 2005; 165(22): 2659-65[DOI][PubMed]
  • 18. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006; 164(3): 263-71[DOI][PubMed]
  • 19. Chen J, Wildman RP, Gu D, Kusek JW, Spruill M, Reynolds K, et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int. 2005; 68(6): 2837-45[DOI][PubMed]
  • 20. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006; 70(4): 751-6[DOI][PubMed]
  • 21. Nafar M, Mousavi SM, Mahdavi-Mazdeh M, Pour-Reza-Gholi F, Firoozan A, Einollahi B, et al. Burden of chronic kidney disease in Iran: a screening program is of essential need. Iran J Kidney Dis. 2008; 2(4): 183-92[PubMed]
  • 22. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009; 9: 44[DOI][PubMed]
  • 23. Safarinejad MR. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors. J Nephrol. 2009; 22(1): 99-108[PubMed]
  • 24. Ghafari A, Ahmadnezhad E, Sepehrvand N, Hatami S, Zafarshamspoor S, Ayubian B, et al. Screening for asymptomatic kidney disease in high-risk population of Urmia, Iran. Iran J Kidney Dis. 2010; 4(4): 307-11[PubMed]
  • 25. Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One. 2012; 7(9)[DOI][PubMed]
  • 26. Najafi I, Shakeri R, Islami F, Malekzadeh F, Salahi R, Yapan-Gharavi M, et al. Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment. Arch Iran Med. 2012; 15(2): 70-5[PubMed]
  • 27. Khajehdehi P, Malekmakan L, Pakfetrat M, Roozbeh J, Sayadi M. Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study. Iran J Kidney Dis. 2014; 8(2): 109-15[PubMed]
  • 28. Naghibi M, Mojahedi MJ, Jarrahi L, Emadzadeh A, Ahmadi R, Emadzadeh M, et al. Prevalence of chronic kidney disease and its risk factors in Gonabad, Iran. Iran J Kidney Dis. 2015; 9(6): 449-53[PubMed]
  • 29. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9): 604-12[PubMed]
  • 30. Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen SC, et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2003; 42(1): 22-35[PubMed]
  • 31. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17): 2038-47[DOI][PubMed]
  • 32. Amato D, Alvarez-Aguilar C, Castaneda-Limones R, Rodriguez E, Avila-Diaz M, Arreola F, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl. 2005; (97)-7[DOI][PubMed]
  • 33. Cirillo M, Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo NG. Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int. 2006; 70(4): 800-6[DOI][PubMed]
  • 34. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006; 17(8): 2275-84[DOI][PubMed]
  • 35. Nitsch D, Felber Dietrich D, von Eckardstein A, Gaspoz JM, Downs SH, Leuenberger P, et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant. 2006; 21(4): 935-44[DOI][PubMed]
  • 36. Otero A, Gayoso P, Garcia F, de Francisco AL, Epirce study group . Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study. Kidney Int Suppl. 2005; (99)-9[DOI][PubMed]
  • 37. Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005; 16(3): 791-9[DOI][PubMed]
  • 38. Alsuwaida AO, Farag YM, Al Sayyari AA, Mousa D, Alhejaili F, Al-Harbi A, et al. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study. Saudi J Kidney Dis Transpl. 2010; 21(6): 1066-72[PubMed]
  • 39. McDonald SP, Maguire GP, Hoy WE. Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant. 2003; 18(8): 1555-61[PubMed]
  • 40. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003; 14(7 Suppl 2)-8[PubMed]
  • 41. Barahimi H, Najafi I, Esmailian R, Rajaee F, Amini M, Ganji MR. Distribution of albuminuria and low glomerular filtration rate in a rural area, Shahreza, Iran. Iran J Kidney Dis. 2011; 5(6): 374-9[PubMed]
  • 42. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003; 14(11): 2934-41[PubMed]
  • 43. Abrass CK. Overview: obesity: what does it have to do with kidney disease? J Am Soc Nephrol. 2004; 15(11): 2768-72[DOI][PubMed]
  • 44. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care. 2005; 28(10): 2436-40[PubMed]
  • 45. Saber A, Fotuhi F, Rostami Z, Einollahi B, Nemati E. Vitamin D Levels After Kidney Transplantation and the Risk of Cytomegalovirus Infection. Nephro Urol Mon. 2015; 7(6)
  • 46. Futohi F, Saber A, Nemati E, Einollahi B, Rostami Z. Human Leukocyte Antigen Alleles and Cytomegalovirus Infection After Renal Transplantation. Nephrourol Mon. 2015; 7(6)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments